Galligan Andrew H 4
4 · NEVRO CORP · Filed Jan 8, 2020
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Galligan Andrew H
VP of Finance , CFO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-01-06−2,782→ 17,718 totalExercise: $63.23Exp: 2025-11-30→ Common Stock (2,782 underlying) - Exercise/Conversion
Common Stock
2020-01-06$63.23/sh+2,782$175,906→ 56,272 total - Sale
Common Stock
2020-01-06$120.00/sh−2,782$333,840→ 53,490 total
Footnotes (3)
- [F1]Includes 16,773 restricted stock units.
- [F2]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F3]Fully vested.